SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Biodexa Pharmaceuticals Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is an innovative nano saccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is an edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Biodexa Pharmaceuticals Plc - ADR

Biodexa Pharmaceuticals Plc

Biodexa Pharmaceuticals is trending amid discussions about its low float, high short interest, and recent news regarding the enrollment of the first patient in a Phase 2a study for its Type 1 diabetes candidate. The community is actively debating the potential for a short squeeze, upcoming data releases, and the impact of news on the stock's price.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is trending due to high trading volume and a volatile price swing, sparking discussions about a potential short squeeze. The community is weighing the impact of a recent lock-up period expiration against bullish signals like high overnight volume and potential institutional accumulation. Some traders are drawing comparisons to similar situations with HOOD and GME, while others debate the long-term prospects of the stock.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Delta Air Lines is trending as discussions revolve around its earnings report, which spurred optimism regarding business travel expansion and overall performance. The narrowed FY25 free cash flow view and positive EPS outlook are key talking points. Community members are also weighing in on the potential impact of the FAA delays due to the government shutdown.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending as investors discuss its potential in the AI race, particularly following collaborations with NVDA, GOOG, and OpenAI; the community is excited about a possible breakout and are heavily debating price targets, with many feeling the stock is undervalued compared to peers and ripe for significant gains, while partnerships are seen as a catalyst for growth.

PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of beverages, food, and snacks. It operates through the following business segments: Frito-Lay North America (FLNA), Quaker Foods North America (QFNA), PepsiCo Beverages North America (PBNA), Latin America (LatAm), Europe, Africa, Middle East, and South Asia (AMESA), and Asia Pacific, Australia and New Zealand, and China Region (APAC). The FLNA segment consists of branded convenient food businesses in the United States and Canada. The QFNA segment includes cereals, rice, and pasta under the Quaker, Pearl Milling Company, Quaker Chewy, Cap'n Crunch, Life, and Rice-A-Roni brands. The PBNA segment is composed of beverage concentrates, fountain syrups, and finished goods under various beverage brands such as Pepsi, Gatorade, Mountain Dew, Diet Pepsi, Aquafina, Diet Mountain Dew, Sierra Mist, and Mug. The LatAm segment covers beverage, food, and snack businesses in the Latin American region. The Europe segment offers beverage, food, and snack goods in Europe and Sub-Saharan Africa regions. The AMESA segment deals with all beverage and convenient food businesses in Africa, the Middle East, and South Asia. The APAC segment refers to all business operations in the Asia Pacific, Australia and New Zealand, and China region. The company was founded by Donald M. Kendall, Sr. and Herman W. Lay in 1965 and is headquartered in Purchase, NY.

PepsiCo Inc

PepsiCo is trending after exceeding Q2 earnings expectations and maintaining its full-year outlook, leading to community discussions about the company's growth strategy and potential for continued momentum. The appointment of a new CFO is also being discussed. Some analysts believe the stock is undervalued, while others express caution due to volume softness and market conditions.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

UAMY is trending due to a mix of factors including a significant government contract and increased attention to rare earth minerals, with community members discussing the company's growth potential and strategic importance. Discussions also involve the impact of China's export controls on rare earths, potentially benefiting UAMY as a domestic supplier. Bullish sentiment is fueled by the CEO's confidence in the company's future and recent insider buying.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

SERV is trending due to its partnership with DoorDash for autonomous deliveries, sparking community excitement about the potential impact on the company's growth. Discussions also highlight the stock's high short interest and potential gap fill, with some investors expressing long-term bullish sentiment based on Serve Robotics' innovative approach to last-mile automation. The broader context of robotics and AI in delivery services is also contributing to the increased attention.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

American Airlines is trending as community members discuss its potential breakout and overnight moves, with some highlighting option volumes and call activity. Positive sentiment from Delta's earnings and expectations for upcoming UAL and AAL earnings reports on 10/15 and 10/23, respectively, contribute to the conversation. Some traders express concerns about government shutdowns potentially impacting air travel and future guidance.

USELESS

USELESS CRYPTO is trending as the community anticipates a potential breakout and a surge towards a billion-dollar market cap, drawing comparisons to the early days of Shiba Inu. Technical analysis suggests bullish targets upon breaking key resistance levels, while proponents highlight recent whale accumulation as a catalyst. The project's self-aware branding and community-driven hype are central to the ongoing discussion.

American Battery Technology Co. is a technology company, which engages in the development and marketing of lithium-ion batteries. Its projects include recycling plant, United States Advanced Battery Consortium (USABC), and Tonopah flats. The company was founded on October 6, 2011 and is headquartered in Reno, NV.

American Battery Technology Company

American Battery Technology Company ($ABAT) is trending as investors discuss its potential driven by momentum in the domestic lithium supply chain and positive sentiment around future catalysts like the PFS release. The community is focused on potential government stakes and partnerships, drawing comparisons to similar companies in the sector. Some traders are eyeing specific price levels, while others are holding long-term positions with multi-year outlooks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA.

Aimmune Therapeutics Inc

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

AIMT
Aimmune Therapeutics

Feed

News

Sentiment

Fundamentals

Info

Latest AIMT News

AIMT Aimmune Therapeutics